We further investigated the significance of RPSA and 67EBP in CRC using proteomic expression data from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) for 104 patients, with clinicopathological characteristics depicted in Table 1 (Series #3). This evidence concerns the gene RPSA and colorectal carcinoma.